You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
|
|---|---|
| Published in |
Frontiers in Pharmacology, March 2021
|
| DOI | 10.3389/fphar.2021.646676 |
| Pubmed ID | |
| Authors |
Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Roger Paredes, Lourdes Mateu, Carles Quiñones, Carles Perez, Itziar Erkizia, Ignacio Blanco, Alfonso Valencia, Víctor Guallar, Jorge Carrillo, Julià Blanco, Joaquim Segalés, Bonaventura Clotet, Júlia Vergara-Alert, Nuria Izquierdo-Useros |
X Demographics
The data shown below were collected from the profiles of 64 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 25 | 39% |
| Germany | 2 | 3% |
| Venezuela, Bolivarian Republic of | 2 | 3% |
| United States | 1 | 2% |
| United Kingdom | 1 | 2% |
| Mexico | 1 | 2% |
| Unknown | 32 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 52 | 81% |
| Scientists | 9 | 14% |
| Practitioners (doctors, other healthcare professionals) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 56 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 25% |
| Student > Bachelor | 8 | 14% |
| Student > Ph. D. Student | 5 | 9% |
| Student > Master | 4 | 7% |
| Student > Doctoral Student | 3 | 5% |
| Other | 4 | 7% |
| Unknown | 18 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 13% |
| Medicine and Dentistry | 7 | 13% |
| Immunology and Microbiology | 7 | 13% |
| Biochemistry, Genetics and Molecular Biology | 6 | 11% |
| Agricultural and Biological Sciences | 6 | 11% |
| Other | 3 | 5% |
| Unknown | 20 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2022.
All research outputs
#780,886
of 23,306,612 outputs
Outputs from Frontiers in Pharmacology
#250
of 16,749 outputs
Outputs of similar age
#23,064
of 429,646 outputs
Outputs of similar age from Frontiers in Pharmacology
#19
of 733 outputs
Altmetric has tracked 23,306,612 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,749 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 733 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.